Ovarian Cancer (OVC)

  1. OVC00100 Carboplatin_Paclitaxel
  2. OVC00101 Carboplatin_Paclitaxel Hypersensitivity
  3. OVC00102 Dose-dense Carboplatin_Paclitaxel
  4. OVC00200 Carboplatin_Docetaxel
  5. OVC00300 Carboplatin_Paclitaxel_Bevacizumab
  6. OVC00301 Carboplatin_Paclitaxel_Bevacizumab
  7. OVC00400 Bevacizumab 7.5 mg_kg (ICON-7)
  8. OVC00401 Bevacizumab 15 mgkg (GOG-218)
  9. OVC00402 Bevacizumab 10 mg_kg (Aurelia study)
  10. OVC00500 Carboplatin 3 weeks
  11. OVC00600 Cisplatin 50-100 mg_m2
  12. OVC00700 Oral Etoposide
  13. OVC00800 Weekly Gemcitabine D1, 8
  14. OVC00801 Weekly Gemcitabine D 1, 8, 15
  15. OVC00900 Pegylated liposomal doxorubicin regimen (PLD)
  16. OVC01000 Paclitaxel 3 weeks
  17. OVC01001 Weekly Paclitaxel
  18. OVC01100 Docetaxel regimen
  19. OVC01200 Topo 1.25_3 week
  20. OVC01201 Weekly Topotecan
  21. OVC01300 Carboplatin_PLD
  22. OVC01400 Carboplatin_Gemcitabine
  23. OVC01500 Carboplatin_Gemcitabine_Bevacizumab (OCEAN study)
  24. OVC01600 Cisplatin_Paclitaxel
  25. OVC01700 BEP regimen
  26. OVC01800 Cis_Eto D1-5 (EP regimen)
  27. OVC01900 Cis_Eto_ifos (VIP)
  28. OVC02000 Cis-Vinb-Ifos regimen (VeIP)
  29. OVC02100 Cis-Pac-Ifos regimen (TIP)
  30. OVC02200 VAC regimens
  31. OVC02300 Olaparib